Future treatment options for chronic wounds;Therapieoptionen der zukunft bei chronischen wunden

Chirurg

Volumn 79, Issue 6, 2008, Pages 555-559

  Steinstraßer L ^a   Hasler, R ^a   Hirsch, T ^a   Daigeler, A ^a   Langer, S ^a   Steinau, H U ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Chronic wound; Skin substitutes; Wound healing; Wound management; Wound therapy

Indexed keywords

EID: 45449092758     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-008-1504-z     Document Type: Review

References (40)

1. Mustoe TA, O'Shaughnessy K, Kloeters O (2006) Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg 117: 35-41
2. Fonder MA, Lazarus GS, Cowan DA et al. (2008) Treating the chronic wound: a practical approach to the care of nonhealing wounds and wound care dressings. J Am Acad Dermatol 58: 185-206
3. Konig M, Vanscheidt W, Augustin M, Kapp H (2005) Enzymatic versus autolytic debridement of chronic leg ulcers: a prospective randomised trial. J Wound Care 14: 320-323
4. Stoddard SR, Sherman RA, Mason BE et al. (1995) Maggot debridement therapy. An alternative treatment for nonhealing ulcers. J Am Podiatr Med Assoc 85: 218-221
5. Wollina U, Karte K, Herold C, Looks A (2000) Biosurgery in wound healing-the renaissance of maggot therapy. J Eur Acad Dermatol Venereol 14: 285-289
6. Bowling FL, Salgami EV, Boulton AJ (2007) Larval therapy: a novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers. Diabetes Care 30: 370-371
7. Tantawi TI, Gohar YM, Kotb MM et al. (2007) Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers. J Wound Care 16: 379-383
8. Hess CL, Howard MA, Attinger CE (2003) A review of mechanical adjuncts in wound healing: hydrotherapy, ultrasound, negative pressure therapy, hyperbaric oxygen, and electrostimulation. Ann Plast Surg 51: 210-218
9. Al-Kurdi D, Bell-Syer S, Flemming K (2008) Therapeutic ultrasound for venous leg ulcers. Cochrane Database Syst Rev: CD001180
10. Rennekampff HO, Schaller HE, Wisser D, Tenenhaus M (2006) Debridement of burn wounds with a water jet surgical tool. Burns 32: 64-69
11. Robson MC, Stenberg BD, Heggers JP (1990) Wound healing alterations caused by infection. Clin Plast Surg 17: 485-492
12. Kistler D, Eren S, Hettich R (1989) Burns. Primary management and clinical therapy. Versicherungsmedizin 41: 116-121
13. Vogt PM, Andree C, Breuing K et al. (1995) Dry, moist, and wet skin wound repair. Ann Plast Surg 34: 493-499; discussion 499-500
14. Steed DL, Attinger C, Colaizzi T et al. (2006) Guidelines for the treatment of diabetic ulcers. Wound Repair Regen 14: 680-692
15. Webster J, Osborne S (2007) Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev 2: CD004985
16. Steed DL (2006) Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg 117: 143-151
17. Steed DL (1995) Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J Vasc Surg 21: 71-78; discussion 79-81
18. Robson MC, Hill DP, Woodske ME, Steed DL (2000) Wound healing trajectories as predictors of effectiveness of therapeutic agents. Arch Surg 135: 773-777
19. Kranke P, Bennett M, Roeckl-Wiedmann I, Debus S (2004) Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2: CD004123
20. Berendt AR (2006) Counterpoint: hyperbaric oxygen for diabetic foot wounds is not effective. Clin Infect Dis 43: 193-198
21. Chang N, Goodson WH 3rd, Gottrup F, Hunt TK (1983) Direct measurement of wound and tissue oxygen tension in postoperative patients. Ann Surg 197: 470-478
22. Hunt TK, Hopf HW (1997) Wound healing and wound infection. What surgeons and anesthesiologists can do. Surg Clin North Am 77: 587-606
23. Cronje FJ (2005) Oxygen therapy and wound healing-topical oxygen is not hyperbaric oxygen therapy. S Afr Med J 95: 840
24. Kanavel AB (1914) Infections of the hand. Lea & Felbinger, Philadelphia
25. Fleischmann W, Strecker W, Bombelli M, Kinzl L (1993) Vacuum sealing as treatment of soft tissue damage in open fractures. Unfallchirurg 96: 488-492
26. Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W (1997) Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg 38: 553-562
27. DeFranzo AJ, Argenta LC, Marks MW et al. (2001) The use of vacuum-assisted closure therapy for the treatment of lower-extremity wounds with exposed bone. Plast Reconstr Surg 108: 1184-1191
28. Gwan-Nulla DN, Casal RS (2001) Toxic shock syndrome associated with the use of the vacuum-assisted closure device. Ann Plast Surg 47: 552-554
29. Clare MP, Fitzgibbons TC, McMullen ST et al. (2002) Experience with the vacuum assisted closure negative pressure technique in the treatment of non-healing diabetic and dysvascular wounds. Foot Ankle Int 23: 896-901
30. Venturi ML, Attinger CE, Mesbahi AN et al. (2005) Mechanisms and clinical applications of the vacuum-assisted closure (VAC) Device: a review. Am J Clin Dermatol 6: 185-194
31. Gerry R, Kwei S, Bayer L, Breuing KH (2007) Silver-impregnated vacuum-assisted closure in the treatment of recalcitrant venous stasis ulcers. Ann Plast Surg 59: 58-62
32. Zasloff M (1987) Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A 84: 5449-5453
33. Hancock RE (1997) Peptide antibiotics. Lancet 349: 418-422
34. Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3: 710-720
35. Yang D, Biragyn A, Hoover DM et al. (2004) Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol 22: 181-215
36. Hirsch T, Jacobsen F, Steinau HU, Steinstraesser L (2008) Host defense peptides and the new line of defence against multiresistant infections. Protein Pept Lett 15: 238-243
37. Heilborn JD, Nilsson MF, Kratz G et al. (2003) The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 120: 379-389
38. Jacobsen F, Mittler D, Hirsch T et al. (2005) Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections. Gene Ther 12: 1494-1502
39. Steinstraesser L, Ring A, Bals R et al. (2006) The human host defense peptide LL37/hCAP accelerates angiogenesis in PEGT/PBT biopolymers. Ann Plast Surg 56: 93-98
40. Barbul A (2006) WHS Clinical guidelines for chronic wounds. Wound Repair Regen 14 (2): 102-109